Opinion/decision on a Paediatric investigation plan (PIP): Prevymis, Letermovir, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0455/2023

EMEA-000737-PIP02-11-M03

Vabysmo

Human medicines European public assessment report (EPAR): Entecavir Accord, entecavir, Date of authorisation: 25/09/2017, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Mozobil, plerixafor, Date of authorisation: 30/07/2009, Revision: 25, Status: Authorised

Use of raw data in medicine evaluation

Human medicines European public assessment report (EPAR): DuoResp Spiromax, budesonide,formoterol, Date of authorisation: 28/04/2014, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): BiResp Spiromax, budesonide,formoterol, Date of authorisation: 28/04/2014, Revision: 13, Status: Authorised

HMA-EMA joint Big Data Steering Group

Big Data Steering Group